Stockscreener 앱 받기
7.595
6.70%
-0.545
시간 외 거래:
7.60
0.005
+0.07%
전일 마감가:
$8.14
열려 있는:
$7.985
하루 거래량:
18,409
Relative Volume:
2.21
시가총액:
$70.49M
수익:
$70,100
순이익/손실:
$-9.67M
주가수익비율:
-6.598
EPS:
-1.1511
순현금흐름:
$-7.09M
1주 성능:
-9.91%
1개월 성능:
-18.68%
6개월 성능:
-23.28%
1년 성능:
-25.42%
1일 변동 폭
$7.35
$8.50
1주일 범위
$7.35
$8.70
52주 변동 폭
$6.33
$18.40
Exozymes Inc Stock (EXOZ) Company Profile
명칭
Exozymes Inc
전화
(626) - 415 - 1488
주소
750 ROYAL OAKS DR, MONROVIA
Compare EXOZ vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EXOZ
Exozymes Inc
|
7.595 | 75.55M | 70,100 | -9.67M | -7.09M | -1.1511 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Exozymes Inc 주식(EXOZ)의 최신 뉴스
If You Invested $1,000 in Invizyne Technologies Inc (IZTC) - Stock Titan
Enterprise value to revenue forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
Price to earnings forward of eXoZymes Inc. – NASDAQ:EXOZ - TradingView
eXoZymes Completes New Securities Offering to Fund Pipeline - TipRanks
eXoZymes Raises $0.64 Million Via Unit Offering; Adds MDB Placement Pact and Warrant Coverage - TradingView
eXoZymes (NASDAQ: EXOZ) raises $639K in unit sale with resettable warrants - Stock Titan
Form 424B5 eXoZymes Inc For: 30 June - Investing.com UK
Form 424B5 eXoZymes Inc For: 30 June By Investing.com - Investing.com Canada
eXoZymes (EXOZ) raises net $565K; warrants exercisable 6/5/2027–2031 - Stock Titan
eXoZymes Inc (EXOZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
eXoZymes Secures $2M NIH Grant to Advance AI-Engineered Cannabinoid Analogs for Drug Discovery - Minichart
eXoZymes Secures NIH Grant to Advance Cannabinoid Pipeline - TipRanks
eXoZymes awarded $2.03M NIH SBIR grant to develop cannabinoid analogs - TradingView
eXoZymes (NASDAQ: EXOZ) lands $2,028,518 NIH grant for cannabinoid analog R&D - Stock Titan
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - The National Law Review
eXoZymes Inc (EXOZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
exoZymes receives $2M NIH grant for cannabinoid research - Investing.com
EXoZymes receives $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - marketscreener.com
eXoZymes stock rises on $2M NIH grant for cannabinoid work - Investing.com South Africa
eXoZymes stock rises on $2M NIH grant for cannabinoid work By Investing.com - Investing.com Australia
NIH backs eXoZymes' cannabinoid drug discovery work with $2M grant - Stock Titan
eXoZymes Inc (EXOZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
eXoZymes Inc (EXOZ) Institutional Confidence - TradingKey
eXoZymes Inc (EXOZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
eXoZymes Inc (EXOZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
eXoZymes Inc (EXOZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
eXoZymes Inc (EXOZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
eXoZymes closes $5.95M public offering of stock and warrants By Investing.com - Investing.com Australia
eXoZymes Inc (EXOZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
eXoZymes Completes Nasdaq Equity Offering to Fund Pipeline - TipRanks
Exozymes Raises $5.95 Million in Underwritten Equity Offering Led by MDB Capital - TradingView
eXoZymes (NASDAQ: EXOZ) closes $5.95M stock and warrant unit offering - Stock Titan
eXoZymes closes $5.95M public offering of stock and warrants - Investing.com
eXoZymes Inc. Announces Closing of $6 Million Public Offering - Newswire.com
eXoZymes closes $5.95 million public offering to fund development - scanx.trade
eXoZymes Inc. (EXOZ) Rises 3.3% as Biotech Momentum Builds, Testing Key Resistance at $7.97Continuation Pattern Picks - newsline.com
eXoZymes (EXOZ) Prices Public Offering of Units - GuruFocus
eXoZymes Announces Public Equity Offering to Fund Growth - TipRanks
eXoZymes Prices $18 Unit Equity Offering; MDB Capital Underwrites $5.33 Million Deal - TradingView
eXoZymes (NASDAQ: EXOZ) sells units in $5.3M underwritten offering - Stock Titan
eXoZymes prices $5.33M offering of units at $18/unit - scanx.trade
exozymes prices $5.3M public offering at $18 per unit - Investing.com
exozymes prices $5.3M public offering at $18 per unit By Investing.com - Investing.com South Africa
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - ACCESS Newswire
AI enzyme firm eXoZymes prices $5.33M unit deal with resettable warrants - Stock Titan
eXoZymes (NASDAQ: EXOZ) sells 592,270 shares and 296,135 warrants in $18 units - Stock Titan
EXOZ Technical Analysis | Trend, Signals & Chart Patterns | EXOZYMES INC (NASDAQ:EXOZ) - ChartMill
eXoZymes (EXOZ) seeks to sell units of common stock and warrants in offering - Stock Titan
eXoZymes (EXOZ) to sell share-and-warrant units; MDB holds 47.8% - Stock Titan
eXoZymes Inc. (EXOZ) Surges 5.5% – Key Levels to Watch After the RallyCash Secured Put - newsline.com
eXoZymes Inc. (EXOZ) Climbs 3.13% as Biotech Stock Tests Key Resistance at $10.74Inside Day Breakout - The Legal Advocate
Exozymes Inc (EXOZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
2.48%
자본화:
|
볼륨(24시간):